Pub. Date : 2005 Aug
PMID : 16037134
13 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The inhibitory effects of sevoflurane on angiotensin II- induced, p44/42 mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 2 | We designed this study to examine the effects of sevoflurane on Ang II-induced, p44/42 MAPK-mediated contraction of rat aortic smooth muscle. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 3 | We designed this study to examine the effects of sevoflurane on Ang II-induced, p44/42 MAPK-mediated contraction of rat aortic smooth muscle. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 4 | Sevoflurane also dose-dependently depressed Ang II-elicited p44/42 MAPK phosphorylation (P < 0.01 in response to 3.4% and 5.1% sevoflurane). | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 5 | Sevoflurane also dose-dependently depressed Ang II-elicited p44/42 MAPK phosphorylation (P < 0.01 in response to 3.4% and 5.1% sevoflurane). | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 6 | Sevoflurane also dose-dependently depressed Ang II-elicited p44/42 MAPK phosphorylation (P < 0.01 in response to 3.4% and 5.1% sevoflurane). | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 7 | Sevoflurane also dose-dependently depressed Ang II-elicited p44/42 MAPK phosphorylation (P < 0.01 in response to 3.4% and 5.1% sevoflurane). | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 8 | These results suggest that the inhibitory effect of sevoflurane on Ang II-induced vasoconstriction is, at least in part, caused by the inhibition of the p44/42 MAPK-mediated signaling pathway. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 9 | These results suggest that the inhibitory effect of sevoflurane on Ang II-induced vasoconstriction is, at least in part, caused by the inhibition of the p44/42 MAPK-mediated signaling pathway. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 10 | IMPLICATIONS: The present study demonstrates that sevoflurane can dose-dependently inhibit both angiotensin II (Ang II)-induced contraction and p44/42 MAPK phosphorylation of rat aortic smooth muscle. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 11 | IMPLICATIONS: The present study demonstrates that sevoflurane can dose-dependently inhibit both angiotensin II (Ang II)-induced contraction and p44/42 MAPK phosphorylation of rat aortic smooth muscle. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 12 | These data suggest that sevoflurane-produced inhibition of Ang II-induced vasoconstriction is, at least in part, caused by depression of the p44/42 MAPK-mediated signaling pathway. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |
| 13 | These data suggest that sevoflurane-produced inhibition of Ang II-induced vasoconstriction is, at least in part, caused by depression of the p44/42 MAPK-mediated signaling pathway. | Sevoflurane | mitogen activated protein kinase 3 | Rattus norvegicus |